| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, USP |
| Model Number: | 461432-26-8 |
| Minimum Order Quantity: | 10grams |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 461432-26-8 | Apparence: | White Powder |
|---|---|---|---|
| Purity: | 99% | ||
| High Light: | pharmaceutical raw material,medical raw material |
||
Effective Forxiga Dapagliflozin Cas 461432-26-8 Control High Blood Sugar
Quick detail
| Name: | Dapagliflozin |
| CAS No.: | 461432-26-8 |
| Formula: | C21H25ClO6 |
| Molecular Weight: | 408.87 |
| Synonyms: | BMS 512148;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-; |
| Density: | 1.349 g/cm3 |
| Boiling Point: | 609.045 °C at 760 mmHg |
| Flash Point: | 322.139 °C |
| Appearance: | White Powder |
Dapagliflozin Description
Dapagliflozin (ForxigaTM) is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes. Dapagliflozin is a sodium-glucose co-transporter 2 inhibitor. On January 8, 2014, the US Food and Drug Administration (FDA) have approved it for being used in the treatment of type II diabetes. Meanwhile, FDA requires the producers to conduct post-marketing research on drug-related risks.
Dapagliflozin Uses
Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps preventkidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Dapagliflozin works by increasing the removal of sugar by your kidneys.
Mechanism of action
| 1 | Dapagliflozin is in a class of drug called SGLT2 inhibitors. These drugs work by targeting and helping to stop sodium-glucose transport proteins from allowing glucose that has been filtered out of the blood by the kidneys to be reabsorbed back into the blood. |
| 2 |
The SGLT2 proteins are responsible for 90% of the glucose that is reabsorbed into the blood. By inhibiting the SGLT2 proteins, Dapagliflozin allows a significant amount of glucose in the blood to be removed by the kidneys and excreted in the urine.
|
Who should not take dapagliflozin
Dapagliflozin is not suitable for people who:
Dapagliflozin Side effects
Side effects of Dapagliflozin may include:
